Journal of Medicinal Chemistry · 2007 · 71 citations · 8 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryEnzymologyEnzyme InhibitionHistone ModificationsHistone Post-translational ModificationsPotency OptimizationHistone Acetyltransferase InhibitionHistone AcetyltransferasesInhibitor Classification
Cinnamoly compounds 1a-c and 2a-d were designed, synthesized, and in vitro tested as p300 inhibitors. At different degrees, all tested compounds were proven to inactivate p300, particularly, derivative 2c was the most active inhibitor, also showing high specificity for p300 as compared to other histone acetyltransferases. Most notably, 2c showed anti-acetylase activity in mammalian cells. These compounds represent a new class of synthetic inhibitors of p300, characterized by simple chemical structures.
8
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Vasily Ogryzko, R. Louis Schiltz, Valya Russanova et al. · Cell · 1996 · 3K citations · Full text
Acetylation of HIV‐1 integrase by p300 regulates viral integration
Anna Cereseto, Lara Manganaro, María Inés Gutiérrez et al. · The EMBO Journal · 2005 · 181 citations · Full text